High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions
暂无分享,去创建一个
A. Plückthun | K. Müller | K. Müller | W. Strittmatter | D. Riesenberg | A. Krebber | S. Matzku | M. Kujau | U. Horn | W. Strittmatter | A. Krebber | U. Knüpfer | M. Kujau | R. Wenderoth | K. Müller | S. Matzku | A. Plückthun | D. Riesenberg | U. Horn | U. Knüpfer | R. Wenderoth
[1] R. R. Robinson,et al. Escherichia coli secretion of an active chimeric antibody fragment. , 1988, Science.
[2] A. Plückthun,et al. Tetravalent miniantibodies with high avidity assembling in Escherichia coli. , 1995, Journal of molecular biology.
[3] A. Plückthun,et al. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.
[4] R. Glockshuber,et al. The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli. , 1992, Biochemistry.
[5] J. Huston,et al. Medical applications of single-chain antibodies. , 1993, International reviews of immunology.
[6] M. Fanger,et al. Bispecific antibodies. , 1992, Critical reviews in immunology.
[7] W. Deckwer,et al. High cell density cultivation of Escherichia coli at controlled specific growth rate. , 1991, Journal of biotechnology.
[8] A. Plückthun,et al. Functional antibody single-chain fragments from the cytoplasm of Escherichia coli: influence of thioredoxin reductase (TrxB). , 1995, Gene.
[9] E. Haber,et al. Engineered Antibodies as Pharmacological Tools , 1992, Immunological reviews.
[10] A. Plückthun,et al. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. , 1992, Biochemistry.
[11] E. Haber,et al. Protein engineering of single-chain Fv analogs and fusion proteins. , 1991, Methods in enzymology.
[12] R. Turner,et al. An autoclavable glucose biosensor for microbial fermentation monitoring and control , 1995, Biotechnology and bioengineering.
[13] R. Rudolph,et al. Renaturation, Purification and Characterization of Recombinant Fab-Fragments Produced in Escherichia coli , 1991, Bio/Technology.
[14] N. Thornhill,et al. Closed‐loop control of fed‐batch cultures of recombinant Escherichia coli using on‐line HPLC , 1994, Biotechnology and bioengineering.
[15] U. K. Laemmli,et al. Cleavage of structural proteins during , 1970 .
[16] G W Luli,et al. A predictive and feedback control algorithm maintains a constant glucose concentration in fed-batch fermentations , 1991, Applied and environmental microbiology.
[17] K. Gerdes,et al. Mechanism of post‐segregational killing: translation of Hok, SrnB and Pnd mRNAs of plasmids R1, F and R483 is activated by 3′‐end processing. , 1994, The EMBO journal.
[18] A. Plückthun,et al. Improved Bivalent Miniantibodies, with Identical Avidity as Whole Antibodies, Produced by High Cell Density Fermentation of Escherichia coli , 1993, Nature Biotechnology.
[19] U. Rinas,et al. Simple fed-batch technique for high cell density cultivation of Escherichia coli. , 1995, Journal of biotechnology.
[20] J. Oelze. Wachstum von Mikroorganismen. Experimente und Modelle. Von Friedrich Bergter. 2. überarb. Aufl. 161 S., 90 Abb., 3 Tab. Verlag Chemie/Physik Verlag, Weinheim 1983. DM 78,– , 1984 .
[21] T. Kuzel,et al. Antibodies in the treatment of human cancer , 1994, Current opinion in oncology.
[22] J. Condra,et al. Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells. , 1990, Journal of Biological Chemistry.
[23] S. Carroll,et al. Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[24] W. Strohl,et al. Developments in high cell density and high productivity microbial fermentation. , 1994, Current opinion in biotechnology.
[25] K. Gerdes,et al. The parB (hok/sok) Locus of Plasmid R1: A General Purpose Plasmid Stabilization System , 1988, Bio/Technology.
[26] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.
[27] A. Plückthun. Mono‐ and Bivalent Antibody Fragments Produced in Escherichia coli: Engineering, Folding and Antigen Binding , 1992, Immunological reviews.
[28] M. Ptashne,et al. Gene regulation at the right operator (OR) bacteriophage lambda. I. OR3 and autogenous negative control by repressor. , 1980, Journal of molecular biology.
[29] G. Bennett,et al. Modification of central metabolic pathway in escherichia coli to reduce acetate accumulation by heterologous expression of the bacillus subtilis acetolactate synthase gene , 1994, Biotechnology and bioengineering.
[30] A. Plückthun. Escherichia coli producing recombinant antibodies. , 1994, Bioprocess technology.
[31] Erik Remaut,et al. Tight Transcriptional Control Mechanism Ensures Stable High-Level Expression from T7 Promoter-Based Expression Plasmids , 1995, Bio/Technology.
[32] T. Nohno,et al. Cloning and sequencing of the Escherichia coli chlEN operon involved in molybdopterin biosynthesis , 1988, Journal of bacteriology.
[33] Brad Snedecor,et al. High Level Escherichia coli Expression and Production of a Bivalent Humanized Antibody Fragment , 1992, Bio/Technology.
[34] Automatic Aseptic Sampling of Fermentation Broth , 1990, Bio/Technology.
[35] K. Ansell,et al. Isolation of tumor cell‐specific single‐chain Fv from immunized mice using phage‐antibody libraries and the re‐construction of whole antibodies from these antibody fragments , 1994, European journal of immunology.
[36] B. Palsson,et al. Metabolic Flux Balancing: Basic Concepts, Scientific and Practical Use , 1994, Bio/Technology.
[37] T. Holak,et al. Characterization of the linker peptide of the single‐chain Fv fragment of an antibody by NMR spectroscopy , 1993, FEBS letters.
[38] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[39] J. Neway,et al. Improved expression of human interleukin-2 in high-cell-density fermentor cultures of Escherichia coli K-12 by a phosphotransacetylase mutant , 1990, Applied and environmental microbiology.
[40] A. Plückthun,et al. The Functional Expression of Antibody Fv Fragments in Ischhuchia coli: Improved Vectors and a Generally Applicable Purification Technique , 1991, Bio/Technology.
[41] G. Bennett,et al. Effect of modified glucose uptake using genetic engineering techniques on high‐level recombinant protein production in escherichia coli dense cultures , 1994, Biotechnology and bioengineering.
[42] A. Plückthun,et al. Engineered turns of a recombinant antibody improve its in vivo folding. , 1995, Protein engineering.
[43] H R Hoogenboom,et al. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. , 1991, Nucleic acids research.
[44] T. Clackson,et al. Making antibody fragments using phage display libraries , 1991, Nature.
[45] M. Whitlow,et al. Single-chain Fv proteins and their fusion proteins , 1991 .
[46] M. Pfreundschuh,et al. Tumor Therapy by Immune Recruitment with Bispecific Antibodies , 1995, Immunological reviews.
[47] M. Herlyn,et al. Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. , 1987, Cancer research.
[48] D. Belin,et al. Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli. , 1993, Science.
[49] S. Lee. HIGH CELL DENSITY CULTIVATION OF ESCHERICHIA COLI , 1996 .